Immunopathology of rsv: An updated review

Harrison C. Bergeron, Ralph A. Tripp

Research output: Contribution to journalReview articlepeer-review

36 Citations (Scopus)
65 Downloads (Pure)


RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.

Original languageEnglish
Article number2478
Pages (from-to)1-30
Number of pages30
Issue number12
Publication statusPublished - Dec 2021
Externally publishedYes


Dive into the research topics of 'Immunopathology of rsv: An updated review'. Together they form a unique fingerprint.

Cite this